The domestic selling price of Bosutinib

The original drug of Bosutinib has not yet been launched in mainland China, so the specific domestic selling price and medical insurance reimbursement information are unclear. If patients consider using bosutinib, they need to obtain it through overseas drug purchase channels or imported pharmacies, and conduct treatment under the guidance of a doctor. Although it is not on the market in China, there are many original and generic versions of bosutinib in overseas markets, with large price differences.

Overseas, the Swiss, Turkish and European versions of bosutinib’s original drug are available for purchase. Taking the Turkish version as an example, its specification is 500mg*28 tablets per box, and the price is about more than 2,000 yuan. The price of the European and Swiss versions of the original drugs is higher, which may exceed 20,000 yuan per box. The price may change due to exchange rate fluctuations. The ingredients, efficacy and safety of these original versions of the drugs are consistent with domestic drug standards and can meet the long-term treatment needs of chronic myelogenous leukemia (CML) patients.

In addition to original drugs, there are also generic drugs produced in many countries in overseas markets. The ingredients of these generic drugs are basically the same as the original drugs, but the price is relatively low. For example, the specifications of bosutinib produced by Indian pharmaceutical companies are 100mg*120 tablets per box, and the price may be more than 1,000 yuan. The emergence of generic drugs provides patients with more affordable options while ensuring that they are as effective as the original drugs. When choosing generic drugs, patients need to confirm that the source is formal and avoid using drugs from non-certified sources to ensure the safety of treatment.

It should be noted that long-term use of bosutinib usually requires continuous monitoring of blood, liver function and cardiovascular indicators. Whether purchasing original drugs or generic drugs, patients should follow the doctor's prescription and medication regimen, and should not adjust the dosage or stop taking the medication on their own. At the same time, overseas drug purchasing channels may involve transportation time and customs procedures. Patients should make arrangements in advance before planning to take medication to ensure the continuity of treatment.

Reference materials:https://go.drugbank.com/drugs/DB06616